-
公开(公告)号：US20230293558A1
公开(公告)日：2023-09-21
申请号：US17903080
申请日：2022-09-06
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini
IPC: A61K31/675 , A61K31/4045 , C12N15/52 , C12P17/10 , C12N9/12 , C12N9/02 , C12N9/10
CPC classification number: A61K31/675 , A61K31/4045 , C12N15/52 , C12P17/10 , C12N9/1205 , C12N9/0083 , C12N9/1007
Abstract: Disclosed are novel halogenated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced using a biosynthetic system which comprises cells comprising a psilocybin biosynthetic enzyme complement.
-
公开(公告)号：US11707447B1
公开(公告)日：2023-07-25
申请号：US17893122
申请日：2022-08-22
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Kaveh Matinkhoo , Peter J. Facchini
IPC: A61K31/4045 , C07D209/16 , A61P25/00 , C07D209/20
CPC classification number: A61K31/4045 , A61P25/00 , C07D209/20 , C07D209/16
Abstract: Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
-
公开(公告)号：US20230043896A1
公开(公告)日：2023-02-09
申请号：US17903103
申请日：2022-09-06
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: C07D209/16
Abstract: Disclosed are novel hydroxylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced synthetically or biosynthetically.
-
公开(公告)号：US12195439B1
公开(公告)日：2025-01-14
申请号：US18494382
申请日：2023-10-25
Applicant: Enveric Biosciences Canada Inc.
Inventor： Kaveh Matinkhoo , David James Press , Glynnis Elizabeth Jensen , Jillian M. Hagel , Peter J. Facchini
IPC: C07D317/58 , A61P25/00 , C07D319/18 , C07D405/06
Abstract: Disclosed are novel fused mescaline derivative compounds, notably C1-substituted isopropylamine fused heterocyclic mescaline derivatives, including C1-substituted isopropylamine fused dioxolane and fused dioxane mescaline derivatives, and pharmaceutical and recreational drug formulations containing the same. Methods of making and using these compounds are also disclosed.
-
公开(公告)号：US20240299427A1
公开(公告)日：2024-09-12
申请号：US18655793
申请日：2024-05-06
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini
IPC: A61K31/675 , A61K31/4045 , C12N9/02 , C12N9/10 , C12N9/12 , C12N15/52 , C12P17/10
CPC classification number: A61K31/675 , A61K31/4045 , C12N9/0083 , C12N9/1007 , C12N9/1205 , C12N15/52 , C12P17/10
Abstract: Disclosed are novel halogenated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced using a biosynthetic system which comprises cells comprising a psilocybin biosynthetic enzyme complement.
-
Patent Agency Ranking
公开(公告)号：US20240173340A1
公开(公告)日：2024-05-30
申请号：US18390228
申请日：2023-12-20
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: A61K31/675 , A61P25/18
CPC classification number: A61K31/675 , A61P25/18
Abstract: Disclosed are novel multi-substituent psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a substituent containing compound.
-
公开(公告)号：US11931338B2
公开(公告)日：2024-03-19
申请号：US17946508
申请日：2022-09-16
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: A61K31/4045 , A61P25/00 , C07D209/16 , C12N9/10 , C12N9/88 , C12N15/52 , C12P17/10
CPC classification number: A61K31/4045 , A61P25/00 , C07D209/16 , C12N9/1007 , C12N9/1029 , C12N9/88 , C12N15/52 , C12P17/10 , C12Y203/01087 , C12Y401/01028 , C12Y402/0102
Abstract: Disclosed are novel nitrilated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a nitrile-group containing compound.
-
公开(公告)号：US11891360B2
公开(公告)日：2024-02-06
申请号：US17941425
申请日：2022-09-09
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: C07D209/20 , C07H17/02
CPC classification number: C07D209/20 , C07H17/02
Abstract: Disclosed are novel glycosylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a hydroxylated psilocybin derivative with a glycosyl compound.
-
公开(公告)号：US11845727B2
公开(公告)日：2023-12-19
申请号：US17951594
申请日：2022-09-23
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Peter J. Facchini , Chang-Chun Ling
IPC: C07D209/16
CPC classification number: C07D209/16
Abstract: Disclosed are novel aldehyde and ketone psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with an aldehyde or ketone group containing compound.
-
公开(公告)号：US11845726B2
公开(公告)日：2023-12-19
申请号：US17893113
申请日：2022-08-22
Applicant: Enveric Biosciences Canada Inc.
Inventor： Jillian M. Hagel , Kaveh Matinkhoo , Peter J. Facchini
IPC: C07D209/16
CPC classification number: C07D209/16
Abstract: Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.
-
-
-
-
-
-
-
-
-
Search Results
46
records
(took 0.016 seconds)
